These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 10704800

  • 1. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose.
    Molpeceres J, Chacón M, Guzmán M, Aberturas MR, Berges L.
    Int J Pharm; 2000 Mar 20; 197(1-2):129-41. PubMed ID: 10704800
    [Abstract] [Full Text] [Related]

  • 2. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats.
    Molpeceres J, Chacón M, Aberturas MR, Guzmán M, Díez ML, Rodriguez-Puyol M.
    Pharmazie; 2001 Jan 20; 56(1):78-82. PubMed ID: 11210676
    [Abstract] [Full Text] [Related]

  • 3. A modified fluorescence polarization immunoassay method incorporating fat emulsion (FE-FPIA) to determine cyclosporin A concentrations in rat skin.
    Kurosaki Y, Asada T, Yasumoto N, Nakamura T, Masada M, Kawasaki H.
    Biol Pharm Bull; 1999 May 20; 22(5):539-42. PubMed ID: 10375179
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
    Varela MC, Guzmán M, Molpeceres J, del Rosario Aberturas M, Rodríguez-Puyol D, Rodríguez-Puyol M.
    Eur J Pharm Sci; 2001 Feb 20; 12(4):471-8. PubMed ID: 11231114
    [Abstract] [Full Text] [Related]

  • 5. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
    Khoschsorur G, Auer T, Lanzer G, Petritsch P, Holzer H, Tscheliessnigg KH.
    Angiology; 1998 Apr 20; 49(4):307-14. PubMed ID: 9555934
    [Abstract] [Full Text] [Related]

  • 6. [Cyclosporine disposition in living related donor partial liver transplant recipients].
    Tada A, Tsuboughi S, Zenda H, Matsunami H, Ikegami T, Hashikura Y, Kitahara S, Terada M, Ishizone S, Kawasaki S.
    Yakugaku Zasshi; 1993 Jan 20; 113(1):84-93. PubMed ID: 8463960
    [Abstract] [Full Text] [Related]

  • 7. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
    Sugioka N, Fujimoto K, Tanaka Y, Fukushima K, Ito Y, Kokuhu T, Okamoto M, Yoshimura N, Takada K.
    Drug Metab Lett; 2009 Aug 20; 3(3):152-61. PubMed ID: 19702545
    [Abstract] [Full Text] [Related]

  • 8. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
    Cárcel-Trullols J, Torres-Molina F, Araico A, Saadeddin A, Peris JE.
    Cancer Chemother Pharmacol; 2004 Aug 20; 54(2):153-60. PubMed ID: 15114410
    [Abstract] [Full Text] [Related]

  • 9. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.
    Molpeceres J, Chacón M, Guzmán M, Berges L, del Rosario Aberturas M.
    Int J Pharm; 1999 Sep 30; 187(1):101-13. PubMed ID: 10502617
    [Abstract] [Full Text] [Related]

  • 10. Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals.
    Wacher VJ, Liu T, Roberts JP, Ascher NL, Benet LZ.
    Biopharm Drug Dispos; 1995 May 30; 16(4):303-12. PubMed ID: 7548779
    [Abstract] [Full Text] [Related]

  • 11. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.
    Tanaka C, Kawai R, Rowland M.
    Drug Metab Dispos; 2000 May 30; 28(5):582-9. PubMed ID: 10772639
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation.
    Shinohara H, Shimada M, Ogasawara T, Morine Y, Ikemoto T, Imura S, Fujii M.
    Dig Dis Sci; 2007 Oct 30; 52(10):2490-6. PubMed ID: 17431772
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
    Shibata N, Shimakawa H, Minouchi T, Yamaji A.
    Biol Pharm Bull; 1993 Nov 30; 16(11):1130-5. PubMed ID: 8312870
    [Abstract] [Full Text] [Related]

  • 14. Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients.
    Nakamura T, Kakumoto M, Sakaeda T, Nagahiro K, Ohmichi R, Yamashita K, Nishiguchi K, Hirai M, Okumura K.
    Biol Pharm Bull; 2001 Jun 30; 24(6):683-7. PubMed ID: 11411559
    [Abstract] [Full Text] [Related]

  • 15. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
    Kees F, Bucher M, Schweda F, Gschaidmeier H, Burhenne J, Mikus G, Faerber L.
    Ther Drug Monit; 2006 Jun 30; 28(3):312-20. PubMed ID: 16778713
    [Abstract] [Full Text] [Related]

  • 16. A nomogram for predicting optimal dosage of cyclosporine in renal transplant patients: taking physiological factors into consideration for regimen during immunosuppressive therapy.
    Shibata N, Hoshino N, Minouchi T, Yamaji A.
    Biol Pharm Bull; 1995 Oct 30; 18(10):1423-9. PubMed ID: 8593449
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I, Nakayama J, Murakami H, Hori Y, Higuchi S.
    Int J Clin Pharmacol Ther; 1996 Mar 30; 34(3):106-11. PubMed ID: 8705088
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of instrumental, nonisotopic immunoassays (fluorescence polarization immunoassay and enzyme-multiplied immunoassay technique) for cyclosporine monitoring in whole blood after kidney and liver transplantation.
    Beutler D, Molteni S, Zeugin T, Thormann W.
    Ther Drug Monit; 1992 Oct 30; 14(5):424-32. PubMed ID: 1448852
    [Abstract] [Full Text] [Related]

  • 19. [Critical analysis of the immunosuppressive activity and of the toxicity of cyclosporine metabolites].
    Garraffo R.
    Therapie; 1992 Oct 30; 47(4):311-7. PubMed ID: 1494794
    [Abstract] [Full Text] [Related]

  • 20. 12-hour area under the curve cyclosporine concentrations determined by a validated liquid chromatography-mass spectrometry procedure compared with fluorescence polarization immunoassay reveals sirolimus effect on cyclosporine pharmacokinetics.
    Napoli KL.
    Ther Drug Monit; 2006 Dec 30; 28(6):726-36. PubMed ID: 17164687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.